Reblozyl vs. FeRiva

Reviewed on 12/10/2019

Are Reblozyl and FeRiva the Same Thing?

Reblozyl (luspatercept-aamt) and FeRiva 21/7 (ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acid, docusate sodium and succinic acid tablet) are used to treat different types of anemia.

Reblozyl is used to treat anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

FeRiva 21/7 is used to improve the nutritional status of patients with iron deficiency.

Reblozyl and FeRiva 21/7 belong to different drug classes. Reblozyl is an erythroid maturation agent and FeRiva 21/7 is a multivitamin/multimineral dietary supplement.

Side effects of Reblozyl that are different from FeRiva include headache, bone pain, joint pain, fatigue, cough, abdominal pain, diarrhea, dizziness, nausea, influenza, high blood pressure (hypertension), high uric acid levels in the blood, viral upper respiratory tract infection, and cough.

Side effects of FeRiva that are different from Reblozyl include allergic reactions.

Both Reblozyl and FeRiva may interact with other medicines.

What Are Possible Side Effects of Reblozyl?

Side effects of Reblozyl include:

  • headache,
  • bone pain,
  • joint pain,
  • fatigue,
  • cough,
  • abdominal pain,
  • diarrhea,
  • dizziness,
  • nausea,
  • influenza,
  • high blood pressure (hypertension),
  • high uric acid levels in the blood,
  • viral upper respiratory tract infection, and
  • cough

What Are Possible Side Effects of FeRiva?

Common side effects of FeRiva include:

  • allergic reactions

What Is Reblozyl?

Reblozyl (luspatercept-aamt) is an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

What Is FeRiva?

FeRiva 21/7 (ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acid, docusate sodium and succinic acid tablet) is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.

QUESTION

Sickle cell disease is named after a farming tool. See Answer

What Drugs Interact With Reblozyl?

Reblozyl may interact with other medicines.

Tell your doctor all medications and supplements you use.

What Drugs Interact With FeRiva?

FeRiva may interact with other drugs.

How Should Reblozyl Be Taken?

The recommended starting dose of Reblozyl is 1 mg/kg once every 3 weeks by subcutaneous injection.

How Should FeRiva Be Taken?

The usual dosage of FeRiva 21/7 is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple placebo tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple placebo tablet daily for 7 days.

SLIDESHOW

Understanding Cancer: Metastasis, Stages of Cancer, and More See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Celgene. Reblozyl Product Information.

https://www.reblozylpro.com/

Avion Pharmaceuticals. FeRiva Product Information.

https://avionrx.com/womens/feriva-217/

Health Solutions From Our Sponsors